Squarepoint’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-484
| Closed | -$17.3K | – | 3061 |
|
|
2024
Q4 | $17.3K | Sell |
484
-2,781
| -85% | -$99.5K | ﹤0.01% | 2716 |
|
|
2024
Q3 | $154K | Sell |
3,265
-6,847
| -68% | -$324K | ﹤0.01% | 2251 |
|
|
2024
Q2 | $508K | Buy |
+10,112
| New | +$508K | ﹤0.01% | 1716 |
|
|
2024
Q1 | – | Sell |
-547
| Closed | -$31.7K | – | 2743 |
|
|
2023
Q4 | $31.7K | Buy |
+547
| New | +$31.7K | ﹤0.01% | 2402 |
|
|
2023
Q3 | – | Sell |
-16,729
| Closed | -$1.38M | – | 2700 |
|
|
2023
Q2 | $1.38M | Buy |
16,729
+16,240
| +3,321% | +$1.34M | ﹤0.01% | 1088 |
|
|
2023
Q1 | $50.3K | Sell |
489
-3,413
| -87% | -$351K | ﹤0.01% | 2110 |
|
|
2022
Q4 | $572K | Buy |
3,902
+3,287
| +534% | +$482K | ﹤0.01% | 1389 |
|
|
2022
Q3 | $104K | Sell |
615
-8,440
| -93% | -$1.43M | ﹤0.01% | 1880 |
|
|
2022
Q2 | $1.05M | Sell |
9,055
-10,505
| -54% | -$1.21M | 0.01% | 1026 |
|
|
2022
Q1 | $1.95M | Buy |
19,560
+16,893
| +633% | +$1.68M | 0.01% | 816 |
|
|
2021
Q4 | $415K | Buy |
+2,667
| New | +$415K | ﹤0.01% | 1706 |
|
|
2021
Q3 | – | Sell |
-1,700
| Closed | -$577K | – | 2555 |
|
|
2021
Q2 | $577K | Sell |
1,700
-517
| -23% | -$175K | ﹤0.01% | 1515 |
|
|
2021
Q1 | $897K | Buy |
2,217
+410
| +23% | +$166K | 0.01% | 1161 |
|
|
2020
Q4 | $1.2M | Buy |
1,807
+1,019
| +129% | +$678K | 0.01% | 965 |
|
|
2020
Q3 | $367K | Sell |
788
-250
| -24% | -$116K | ﹤0.01% | 1547 |
|
|
2020
Q2 | $607K | Buy |
1,038
+554
| +114% | +$324K | 0.01% | 1189 |
|
|
2020
Q1 | $71K | Buy |
+484
| New | +$71K | ﹤0.01% | 1684 |
|